BeOne Medicines AG (ONC)

Nasdaq · Healthcare · Biotechnology
$390.94-2.19%As of 2026-11-22 · USD
Last session low $385.00Last session high $399.75
52-week low $253.9552-week high $424.73
Market cap
$44.66B
Sector
Healthcare
P/E (TTM)
50.1x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)53.8In the neutral range (30 to 70)
MACD (12, 26, 9)10.25Below its signal line (11.34); histogram -1.10
Bollinger %B (20, 2)48%Inside the bands (348.78 to 437.18)
SMA 20392.98Price is 0.5% below
SMA 50374.70Price is 4.3% above
SMA 200329.29Price is 18.7% above
ATR (20)2.93% of priceAverage true range per day
52-week position80%In the upper part of the 253.95 to 424.73 range

About BeOne Medicines AG

BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Insider filings, 90 daysNo purchases and 9 sales (about $48.5M).
Latest fiscal yearEnded 2025-12-31: revenue of $5.34B and an operating margin of 8.4%.

More in Biotechnology